⌘K

Login Start Free

Home/Filings/4/0000950170-23-031386

4//SEC Filing

BB BIOTECH AG 4

Accession 0000950170-23-031386

CIK 0001701541other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 3:36 PM ET

Size

6.3 KB

Accession

0000950170-23-031386

Insider Transaction Report

Form 4

Period: 2023-06-30

Black Diamond Therapeutics, Inc.BDTX

10% Owner

Transactions

Purchase
Common Stock
2023-06-30$5.00/sh+1,000,000$5,000,000→ 8,117,839 total

BIOTECH GROWTH N V

10% Owner

Transactions

Purchase
Common Stock
2023-06-30$5.00/sh+1,000,000$5,000,000→ 8,117,839 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0000924223

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 3:36 PM ET
Size: 6.3 KB

View on SEC.gov